Revelation Partners β Full Portfolio
6 tracked investments Β· listed companies and verified rows first
Biotheryx is a clinical-stage biopharmaceutical company developing first-in-class targeted protein degraders, including molecular glues and bifunctional degraders, with an initial focus on cancer and inflammatory disease.
BiotechDeep TechMedical DevicesSan Diego, US
Kyle Chan, PhD(Executive Officer)Lawrence Zaslow(Executive Officer, Director)inFrank Mercurio, PhD(Executive Officer)Leah Fung(Chief Executive Officer & Board Member (former Chief Scientific Officer))inRaymond W. Urbanski(Acting Chief Medical Officer)inPhilippe Drouet(Chief Executive Officer)in
Co-investorsLumira VenturesSR One Capital Management
IntelyCare operates a healthcare talent marketplace that connects nurses with care settings including hospitals, clinics, and other healthcare facilities.
B2B MarketplacesFuture of WorkHealthtechHR TechQuincy, US
Ike Nnah(Executive Officer, Director)inDavid Coppins(Executive Officer, Director)inPrince Nnah(Director)
Co-investorsEastward Capital PartnersEndeavour VisionEquitage Ventures, L.L.C.Generator VenturesKaiser Permanente VenturesLongitude Capital+3 more
Nationally recognized leader in the telepsychiatry space.
Metabolon provides metabolomics services and bioinformatics tools that measure small molecules to give biological context to research data.
AI & Machine LearningBiotechHealthtechDurham, US
John A. Ryals(Executive Officer, Director)inGerald M. Haines II(Executive Officer)Rohan F. Hastie(Executive Officer, Director)in
BoardJohn Oxaal(Director)R. Scott Barry(Director)R. John Fletcher(Director)
Co-investorsCamden PartnersEssex Woodlands Healthcare PartnersHavencrest Capital ManagementSyngenta Group Ventures
SPR is a medical device company that develops the SPRINT Peripheral Nerve Stimulation (PNS) System, a non-opioid, non-surgical, minimally invasive treatment for acute and chronic pain.
HardwareHealthtechMedical DevicesCleveland, US
Maria Bennett(President, CEO & Founder)inJosh Boggs(Executive Officer)inMark Stulz(Executive Officer)Marilyn A. Eisele(Executive Officer)Ben Austin(Chief Financial Officer)inDavid Youngberg(Chief Commercial Officer)
Co-investorsJumpstart VenturesMutual Capital PartnersNDIRC CapitalRiver Cities Capital
HealthtechCampbell, US
Nersi Nazari(Executive Officer, Director)Steve Zadig(Executive Officer, Director)
BoardRichard Feachem(Director)Tom Saunders(Director)
Co-investorsAsahi Kasei Corporate Venture CapitalEssex Woodlands Healthcare PartnersAlly Bridge GroupMVM Life Science PartnersTrinity Capital
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.